JP2007502608A5 - - Google Patents

Download PDF

Info

Publication number
JP2007502608A5
JP2007502608A5 JP2006523593A JP2006523593A JP2007502608A5 JP 2007502608 A5 JP2007502608 A5 JP 2007502608A5 JP 2006523593 A JP2006523593 A JP 2006523593A JP 2006523593 A JP2006523593 A JP 2006523593A JP 2007502608 A5 JP2007502608 A5 JP 2007502608A5
Authority
JP
Japan
Prior art keywords
cells
cell
mammalian
feeder
free conditions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006523593A
Other languages
English (en)
Japanese (ja)
Other versions
JP5129959B2 (ja
JP2007502608A6 (ja
JP2007502608A (ja
Filing date
Publication date
Priority claimed from DE10338531A external-priority patent/DE10338531A1/de
Application filed filed Critical
Publication of JP2007502608A publication Critical patent/JP2007502608A/ja
Publication of JP2007502608A6 publication Critical patent/JP2007502608A6/ja
Publication of JP2007502608A5 publication Critical patent/JP2007502608A5/ja
Application granted granted Critical
Publication of JP5129959B2 publication Critical patent/JP5129959B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006523593A 2003-08-19 2004-08-17 生産細胞の再クローン化方法 Expired - Fee Related JP5129959B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10338531A DE10338531A1 (de) 2003-08-19 2003-08-19 Verfahren zur Reklonierung von Produktionszellen
DE10338531.2 2003-08-19
PCT/EP2004/009204 WO2005019442A2 (de) 2003-08-19 2004-08-17 Verfahren zur reklonierung von produktionszellen

Publications (4)

Publication Number Publication Date
JP2007502608A JP2007502608A (ja) 2007-02-15
JP2007502608A6 JP2007502608A6 (ja) 2007-05-10
JP2007502608A5 true JP2007502608A5 (https=) 2007-10-04
JP5129959B2 JP5129959B2 (ja) 2013-01-30

Family

ID=34201814

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006523593A Expired - Fee Related JP5129959B2 (ja) 2003-08-19 2004-08-17 生産細胞の再クローン化方法

Country Status (11)

Country Link
US (1) US7833787B2 (https=)
EP (2) EP1918364B1 (https=)
JP (1) JP5129959B2 (https=)
KR (1) KR101184572B1 (https=)
AT (2) ATE415471T1 (https=)
CA (1) CA2536239C (https=)
DE (2) DE10338531A1 (https=)
DK (2) DK1658365T3 (https=)
ES (2) ES2368772T3 (https=)
TW (1) TWI337201B (https=)
WO (1) WO2005019442A2 (https=)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060223183A1 (en) * 2005-03-11 2006-10-05 Bates Steven E Gamma irradiation of frozen feeder cells
EP1901068A1 (en) * 2006-09-15 2008-03-19 Boehringer Ingelheim Pharma GmbH & Co. KG Methods of selecting cell clones
EP2067038A1 (en) * 2006-09-15 2009-06-10 Boehringer Ingelheim Pharma GmbH & Co. KG Methods of selecting cell clones
EP2257620A1 (de) * 2008-03-19 2010-12-08 Boehringer Ingelheim Pharma GmbH & Co. KG Methode zur steigerung der reklonierungseffizienz
JP5304275B2 (ja) * 2009-01-29 2013-10-02 Jnc株式会社 アポクライティン−iiをコードするコドン最適化核酸およびその使用方法
EP2417248B1 (en) 2009-04-09 2019-05-22 Sartorius Stedim Cellca GmbH Method for improved single cell cloning
CA2781332C (en) * 2009-11-19 2018-09-04 National University Corporation Okayama University System for increasing gene expression and vector comprising the system
RS63930B1 (sr) 2011-10-28 2023-02-28 Prothena Biosciences Ltd Humanizovana antitela koja prepoznaju alfa-sinuklein
DK2807188T3 (da) 2012-01-27 2019-10-07 Prothena Biosciences Ltd Humaniserede antistoffer, der genkender alpha-synuclein
UA118441C2 (uk) 2012-10-08 2019-01-25 Протена Біосаєнсиз Лімітед Антитіло, що розпізнає альфа-синуклеїн
US10501531B2 (en) 2013-03-13 2019-12-10 Prothena Biosciences Limited Tau immunotherapy
US10513555B2 (en) 2013-07-04 2019-12-24 Prothena Biosciences Limited Antibody formulations and methods
US9850302B2 (en) 2013-07-12 2017-12-26 Prothena Biosciences Limited Antibodies that recognize IAPP
WO2015004633A1 (en) 2013-07-12 2015-01-15 Neotope Biosciences Limited Antibodies that recognize islet-amyloid polypeptide (iapp)
JP2017501848A (ja) 2013-11-19 2017-01-19 プロセナ バイオサイエンシーズ リミテッド 便秘症状からのレビー小体病の免疫療法のモニター
KR20160131082A (ko) 2014-03-12 2016-11-15 프로테나 바이오사이언시즈 리미티드 Lg1-3에 특이적인 항-라미닌4 항체
PT3116911T (pt) 2014-03-12 2019-09-04 Prothena Biosciences Ltd Anticorpos anti-mcam e métodos de utilização associados
TW201623331A (zh) 2014-03-12 2016-07-01 普羅帝納生物科學公司 抗黑色素瘤細胞黏著分子(mcam)抗體類及使用彼等之相關方法
JP2017514458A (ja) 2014-03-12 2017-06-08 プロセナ バイオサイエンシーズ リミテッド Lg4−5に対して特異的な抗−ラミニン4抗体
CA2944402A1 (en) 2014-04-08 2015-10-15 Prothena Biosciences Limited Blood-brain barrier shuttles containing antibodies recognizing alpha-synuclein
TWI786505B (zh) 2015-01-28 2022-12-11 愛爾蘭商普羅佘納生物科技有限公司 抗甲狀腺素運送蛋白抗體
TWI718121B (zh) 2015-01-28 2021-02-11 愛爾蘭商普羅佘納生物科技有限公司 抗甲狀腺素運送蛋白抗體
TWI769570B (zh) 2015-01-28 2022-07-01 愛爾蘭商普羅佘納生物科技有限公司 抗甲狀腺素運送蛋白抗體
WO2017046774A2 (en) 2015-09-16 2017-03-23 Prothena Biosciences Limited Use of anti-mcam antibodies for treatment or prophylaxis of giant cell arteritis, polymyalgia rheumatica or takayasu's arteritis
EP3350226A2 (en) 2015-09-16 2018-07-25 Prothena Biosciences Limited Use of anti-mcam antibodies for treatment or prophylaxis of giant cell arteritis, polymyalgia rheumatica or takayasu's arteritis
WO2017149513A1 (en) 2016-03-03 2017-09-08 Prothena Biosciences Limited Anti-mcam antibodies and associated methods of use
WO2017153953A1 (en) 2016-03-09 2017-09-14 Prothena Biosciences Limited Use of anti-mcam antibodies for treatment or prophylaxis of granulomatous lung diseases
WO2017153955A1 (en) 2016-03-09 2017-09-14 Prothena Biosciences Limited Use of anti-mcam antibodies for treatment or prophylaxis of granulomatous lung diseases
MX2018013386A (es) 2016-05-02 2019-02-28 Prothena Biosciences Ltd Anticuerpos que reconocen tau.
MY198194A (en) 2016-05-02 2023-08-09 Prothena Biosciences Ltd Antibodies Recognizing Tau
PT3452507T (pt) 2016-05-02 2022-12-20 Prothena Biosciences Ltd Imunoterapia anti-tau
WO2017208210A1 (en) 2016-06-03 2017-12-07 Prothena Biosciences Limited Anti-mcam antibodies and associated methods of use
WO2018007922A2 (en) 2016-07-02 2018-01-11 Prothena Biosciences Limited Anti-transthyretin antibodies
WO2018007924A2 (en) 2016-07-02 2018-01-11 Prothena Biosciences Limited Anti-transthyretin antibodies
JP7016470B2 (ja) 2016-07-02 2022-02-07 プロセナ バイオサイエンシーズ リミテッド 抗トランスサイレチン抗体
KR102784294B1 (ko) 2017-05-02 2025-03-19 프로테나 바이오사이언시즈 리미티드 타우 인식 항체
WO2019064053A1 (en) 2017-09-28 2019-04-04 Prothena Biosciences Limited DOSAGE REGIMES FOR THE TREATMENT OF SYNUCLEINOPATHIES
AU2018345807B2 (en) 2017-10-06 2025-02-06 Novo Nordisk A/S Methods of detecting transthyretin
PE20211453A1 (es) 2017-11-29 2021-08-05 Prothena Biosciences Ltd Formulacion liofilizada de un anticuerpo monoclonal contra transtirretina
CU24781B1 (es) 2018-11-08 2026-02-09 Prothena Biosciences Ltd Anticuerpos humanizados que reconocen tau
EA202190986A1 (ru) 2018-11-26 2021-12-14 Фоти Севен, Инк. ГУМАНИЗИРОВАННЫЕ АНТИТЕЛА К c-Kit
JP7630834B2 (ja) 2019-03-03 2025-02-18 プロセナ バイオサイエンシーズ リミテッド タウ認識抗体
BR112022026508A2 (pt) 2020-06-24 2023-03-07 Prothena Biosciences Ltd Anticorpos que reconhecem sortilina
WO2025059486A1 (en) 2023-09-15 2025-03-20 Prothena Biosciences Limited Anti-tdp-43 antibodies and uses thereof
WO2025059491A2 (en) 2023-09-15 2025-03-20 Prothena Platform Technologies Limited Methods, compositions, and kits including cell-penetrating agents
AR133834A1 (es) 2023-09-15 2025-11-05 Prothena Biosciences Ltd Agentes de penetración célular y sus usos
TW202530246A (zh) 2023-09-15 2025-08-01 愛爾蘭商歐賽爾普羅希那有限公司 細胞穿透劑及其用途

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0173552B1 (en) 1984-08-24 1991-10-09 The Upjohn Company Recombinant dna compounds and the expression of polypeptides such as tpa
US5008198A (en) 1984-09-14 1991-04-16 Scripps Clinic And Research Foundation Merozoite surface glycoproteins
IE913929A1 (en) 1990-11-13 1992-05-20 Immunex Corp Bifunctional selectable fusion genes
US5459058A (en) * 1991-03-28 1995-10-17 Benjamin Rich Cell culture system
AU6953394A (en) 1993-05-21 1994-12-20 Targeted Genetics Corporation Bifunctional selectable fusion genes based on the cytosine deaminase (cd) gene
DE19539493A1 (de) 1995-10-24 1997-04-30 Thomae Gmbh Dr K Starker homologer Promotor aus Hamster
ES2226383T3 (es) 1998-04-17 2005-03-16 Societe Des Produits Nestle S.A. Linea de celulas inmortalizadas derivadas de tejidos cutaneos humanos normales.
WO2000034318A1 (en) 1998-12-11 2000-06-15 Clontech Laboratories, Inc. Fluorescent proteins from non-bioluminescent species of class anthozoa, genes encoding such proteins and uses thereof
WO2000034319A1 (en) 1998-12-11 2000-06-15 Clontech Laboratories, Inc. Fluorescent proteins from non-bioluminescent species of class anthozoa, genes encoding such proteins and uses thereof
WO2000034326A1 (en) 1998-12-11 2000-06-15 Clontech Laboratories, Inc. Fluorescent proteins from non-bioluminescent species of class anthozoa, genes encoding such proteins and uses thereof
ES2257303T3 (es) 1999-07-12 2006-08-01 Genentech, Inc. Vectores de expresion y procedimientos.
DK1200561T3 (da) * 1999-08-05 2006-10-16 Baxter Ag Rekombinant stabil celleklon, dens fremstilling og anvendelse
US7456017B2 (en) * 1999-10-01 2008-11-25 University Of North Carolina At Chapel Hill Processes for clonal growth of hepatic progenitor cells
JP2003527833A (ja) 1999-10-14 2003-09-24 クロンテック・ラボラトリーズ・インコーポレーテッド 花虫類に由来する発色団/蛍光体、およびそれらの使用法
CN1461341A (zh) * 2000-10-03 2003-12-10 北卡罗来纳大学 肝祖先细胞克隆生长的方法
US20030073234A1 (en) * 2001-10-12 2003-04-17 Michal Amit Clonal human embryonic stem cell lines and methods of generating same

Similar Documents

Publication Publication Date Title
JP2007502608A5 (https=)
JP6177260B2 (ja) 連続細胞培養で対象となるポリペプチドまたはウイルスを生成する方法
JP2010263903A (ja) 哺乳動物細胞中で分泌型組換えタンパク質を高生産させるための分子シャペロンの使用方法
CN109777773A (zh) 一种从造血干细胞分化产生nk细胞的方法及其培养基
Van der Velden-de Groot Microcarrier technology, present status and perspective
CN106414722A (zh) 红系细胞的体外扩增
Prentice et al. Improving performance of mammalian cells in fed‐batch processes through “bioreactor evolution”
CN103320406B (zh) 高活力谷胱甘肽过氧化物酶gpx1突变体及其制备方法
CN106987559A (zh) 一种重组chok1细胞株的构建方法及其应用
CN116716348A (zh) 一种提高重组细胞的蛋白表达量的方法
JP2021512618A (ja) 閉鎖系におけるcar−t細胞の製造方法
Suarez-Patino et al. Transient expression of rabies virus glycoprotein (RVGP) in Drosophila melanogaster Schneider 2 (S2) cells
KR102648479B1 (ko) 단백질 기반 의약들 (protein-based pharmaceuticals) 의 고 수준 생산을 위한 세포주들 (cell lines)
CN116004645B (zh) 一种利用昆虫细胞生产人血清白蛋白的方法、核苷酸序列及表达载体
US20060252152A1 (en) Attachment of cells to surfaces
CN102199623A (zh) 蛋白质精氨酸甲基转移酶5的新用途
JP2006141356A (ja) Es細胞から樹立された造血幹細胞
Despars et al. Heterogeneity amongst splenic stromal cell lines which support dendritic cell hematopoiesis
JP2010004796A (ja) 分化抑制剤、分化抑制基材及び分化抑制方法並びにその使用
Vatandoost et al. A study of recombinant factor IX in Drosophila insect S2 cell lines through transient gene expression technology
CN109517800A (zh) 一株补强胆固醇内源性合成的重构st细胞及其构建方法和用途
Knibbs et al. Sustained high‐yield production of recombinant proteins in transiently transfected COS‐7 cells grown on trimethylamine‐coated (hillex) microcarrier beads
Levine et al. New microcarriers for the large scale production of anchorage-dependent mammalian cells
JP6097725B2 (ja) 組換え安定細胞クローン、その産生およびその使用
WO2020204055A1 (ja) 標的特異的な外来遺伝子の導入方法